Potential Drug Target for KLHL10 (G317719)

Target Name: KLHL10

NCBI ID: G317719

KLHL10

Potential Drug Target for KLHL10

The KLHL10 (KLHL10 variant 2) is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues.

Recent studies have identified KLHL10 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because KLHL10 has been shown to promote the growth and survival of cancer cells, and is involved in the development of neurodegenerate diseases.

One of the key reasons for the potential of KLHL10 as a drug target is its role in cell signaling. KLHL10 is a transcription factor that regulates the expression of genes in response to various signaling pathways. This means that it can influence the activity of cells in response to a wide range of stimuli, including those that promote cell growth and differentiation.

Studies have shown that KLHL10 is involved in many different signaling pathways, including those that promote cancer cell growth and survival. For example, researchers have found that KLHL10 can promote the growth and survival of various types of cancer cells, including breast, lung, and ovarian cancer cells.

Another potential drug target for KLHL10 is its role in the development of neurodegenerate diseases. Neurodegenerate diseases are a group of disorders that are characterized by the progressive loss of brain cells and the development of debilitating symptoms. Many of these diseases, including Alzheimer's disease and Parkinson's disease, are caused by the build-up of plaque in the brain, which is thought to be caused by the presence of mutated genes like KLHL10.

In addition to its role in the development of neurodegenerate diseases, KLHL10 has also been shown to be involved in the development of autoimmune disorders. Autoimmune disorders are a group of conditions that are characterized by the immune system attacking the body's own tissues. KLHL10 has been shown to play a role in the development of autoimmune disorders, and may be a potential drug target for these conditions.

Overall, the potential of KLHL10 as a drug target is due to its role in cell signaling and its involvement in the development of various diseases. Further research is needed to fully understand the effects of KLHL10 on the body and to identify effective treatments for these diseases.

Protein Name: Kelch Like Family Member 10

Functions: May be a substrate-specific adapter of a CUL3-based E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins during spermatogenesis

The "KLHL10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLHL10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets